Search research articles
Contact Us
Filters
Showing results (1-10 of 136) with videos related to
Page
of 14
Sort By:
Journal of Psychopharmacology (Oxford, England)
|
April 29, 2006
Improving depression outcome: new concepts, strategies and technologies
Jonathan E Alpert
Bipolar Disorders
|
September 19, 2020
A vote for the full ticket
Simon A Rego, Jonathan E Alpert
Bipolar Disorders
|
March 10, 2020
Stretching beyond the evidence base
Simon A Rego, Jonathan E Alpert
The Medical Clinics of North America
|
October 19, 2010
An approach to the psychopharmacologic care of patients: antidepressants, antipsychotics, anxiolytics, mood stabilizers, and natural remedies
Jeff C Huffman, Jonathan E Alpert
Dialogues in Clinical Neuroscience
|
January 28, 2009
Toward achieving optimal response: understanding and managing antidepressant side effects
Karen Kelly, Michael Posternak, Jonathan E Alpert
Current Psychiatry Reports
|
November 12, 2003
S-adenosyl-methionine in depression: a comprehensive review of the literature
George I Papakostas, Jonathan E Alpert, Maurizio Fava
JAMA Network Open
|
February 25, 2026
Purposeful Discontinuation of Psychotropic Medications
Eric A Nelson, Rubiahna Vaughn, Jonathan E Alpert
Dialogues in Clinical Neuroscience
|
August 7, 2015
Pharmacological approaches to the challenge of treatment-resistant depression
Dawn F Ionescu, Jerrold F Rosenbaum, Jonathan E Alpert
The Journal of Clinical Psychiatry
|
December 9, 2003
Prevention of relapse and recurrence in depression: the role of long-term pharmacotherapy and psychotherapy
Andrew A Nierenberg, Timothy J Petersen, Jonathan E Alpert
Joint Commission Journal on Quality and Patient Safety
|
December 23, 2020
Staff Emotional Support at Montefiore Medical Center During the COVID-19 Pandemic
Carol A Bernstein, Sriya Bhattacharyya, Shelby Adler, et al.
Page
of 14
Search research articles
Search
Showing results (1-10 of 136) with videos related to
Sort By:
Page
of 14
Journal of Psychopharmacology (Oxford, England)
|
April 29, 2006
Improving depression outcome: new concepts, strategies and technologies
Jonathan E Alpert
Bipolar Disorders
|
September 19, 2020
A vote for the full ticket
Simon A Rego, Jonathan E Alpert
Bipolar Disorders
|
March 10, 2020
Stretching beyond the evidence base
Simon A Rego, Jonathan E Alpert
The Medical Clinics of North America
|
October 19, 2010
An approach to the psychopharmacologic care of patients: antidepressants, antipsychotics, anxiolytics, mood stabilizers, and natural remedies
Jeff C Huffman, Jonathan E Alpert
Dialogues in Clinical Neuroscience
|
January 28, 2009
Toward achieving optimal response: understanding and managing antidepressant side effects
Karen Kelly, Michael Posternak, Jonathan E Alpert
Current Psychiatry Reports
|
November 12, 2003
S-adenosyl-methionine in depression: a comprehensive review of the literature
George I Papakostas, Jonathan E Alpert, Maurizio Fava
JAMA Network Open
|
February 25, 2026
Purposeful Discontinuation of Psychotropic Medications
Eric A Nelson, Rubiahna Vaughn, Jonathan E Alpert
Dialogues in Clinical Neuroscience
|
August 7, 2015
Pharmacological approaches to the challenge of treatment-resistant depression
Dawn F Ionescu, Jerrold F Rosenbaum, Jonathan E Alpert
The Journal of Clinical Psychiatry
|
December 9, 2003
Prevention of relapse and recurrence in depression: the role of long-term pharmacotherapy and psychotherapy
Andrew A Nierenberg, Timothy J Petersen, Jonathan E Alpert
Joint Commission Journal on Quality and Patient Safety
|
December 23, 2020
Staff Emotional Support at Montefiore Medical Center During the COVID-19 Pandemic
Carol A Bernstein, Sriya Bhattacharyya, Shelby Adler, et al.
Page
of 14